# Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers

> **NCT00845741** · — · COMPLETED · sponsor: **Abbott RDx Cardiometabolic** · enrollment: 700 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00845741
- **Lead sponsor:** Abbott RDx Cardiometabolic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-06
- **Final completion:** 2010-08
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845741, "Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00845741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*